Avidity Biosciences, Inc. Insider Teresa Mccarthy Sells 25,000 Shares of Stock
RNA Stock | USD 43.03 0.30 0.69% |
About 57% of Avidity Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Avidity Biosciences suggests that many traders are alarmed. The current market sentiment, together with Avidity Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Avidity Biosciences stock news signals to limit their universe of possible portfolio assets.
Avidity |
Avidity Biosciences, Inc. insider Teresa Mccarthy sold 25,000 shares of the firms stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of 48.52, for a total transaction of 1,213,000.00. Following the completion of the sale, the insider now owns 94,018 shares
Read at thelincolnianonline.com
Avidity Biosciences Current Investor Sentiment
Panic Vs Confidence
43
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Avidity Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Avidity Biosciences.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Avidity Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Avidity Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Avidity Biosciences Historical Investor Sentiment
Investor biases related to Avidity Biosciences' public news can be used to forecast risks associated with an investment in Avidity. The trend in average sentiment can be used to explain how an investor holding Avidity can time the market purely based on public headlines and social activities around Avidity Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Avidity Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Avidity Biosciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Avidity Biosciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Avidity Biosciences.
Avidity Biosciences Fundamental Analysis
We analyze Avidity Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avidity Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avidity Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Avidity Biosciences is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Avidity Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avidity Biosciences stock to make a market-neutral strategy. Peer analysis of Avidity Biosciences could also be used in its relative valuation, which is a method of valuing Avidity Biosciences by comparing valuation metrics with similar companies.
Peers
Avidity Biosciences Related Equities
PASG | Passage Bio | 68.66 | ||||
BDTX | Black Diamond | 3.11 | ||||
ARVN | Arvinas | 2.85 | ||||
CGEM | Cullinan Oncology | 2.75 | ||||
PLRX | Pliant Therapeutics | 2.00 | ||||
STOK | Stoke Therapeutics | 1.68 | ||||
DAWN | Day One | 1.53 | ||||
AKRO | Akero Therapeutics | 0.22 | ||||
SWTX | SpringWorks Therapeutics | 0.60 | ||||
RVMD | Revolution Medicines | 1.25 | ||||
RLAY | Relay Therapeutics | 2.08 | ||||
PTGX | Protagonist Therapeutics | 2.56 | ||||
MLYS | Mineralys Therapeutics, | 2.59 | ||||
IGMS | IGM Biosciences | 3.74 |
Complementary Tools for Avidity Stock analysis
When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
CEOs Directory Screen CEOs from public companies around the world |